Parent Testimonials

Affordable Cord Blood Banking for Everyone

Stem Cells could save your child’s life

#1 in Europe


Stem cells are a powerful tool in combating diseases and illnesses.

The potential of stem cells is limitless, as they are the body’s fundamental components for regeneration and renewal.

Banking your baby’s umbilical cord stem cells opens up a plethora of potential treatment options for more than 80 illnesses, with clinical trials underway to research even more applications, including treatment of COVID-19.


  • Acute Leukaemia
  • Chronic Leukaemia
  • High-Risk Solid Tumors
  • Hodgkin & Non-Hodgkin Lymphoma
  • Myelodysplastic Syndromes

Blood disorders

  • Aplastic Anaemia
  • Beta Thalassemia
  • Diamond-Blackfan Anaemia
  • Fanconi’s Anaemia
  • Sickle Cell Disease

Neurological disorders

  • Traumatic Brain Injury
  • Cerebral Palsy
  • Hypoxic Ischemic Encephalopathy (HIE)
  • HSV Encephalitis & NMDA Receptor
  • Antibody Encephalitis

Immune disorders

  • Chronic Granulomatous Disease
  • Hystiocytic Disorders
  • Leukocyte Adhesion Deficiency
  • Severe Combined Immunodeficiency
  • Wiskott- Aldrich Syndrome

Metabolic disorders

  • Krabbe Disease
  • Hurler Syndrome
  • Metachromatic Leukodystrophy
  • Sanfilippo Syndrome
  • Hunter Syndrome

So much more than just a stem cell bank!

Parents around the globe are opting to store stem cells, so they can be assured that their little one’s health is safeguarded for years to come. In the last four decades, private cord blood banks have fostered an astonishing 4 million samples worldwide.

Smart Cells, an esteemed private cord blood company in the UAE, is renowned as one of the pioneers of UK Stem cell banking. With over 500,000 families placing their trust in us as part of the FamiCord Group, we are now Europe’s top cord blood & tissue banking organization with a dedication to achieve an outstanding reputation in the UAE as well. Our unwavering commitment to Stem Cell research and the expansive variety of therapies developed are unparalleled.

500,000 families have
put their trust in us

With over 20 years’ experience

FamiCord Group releases





Multiple myeloma


Cerebral palsy




Spinal cord injury


Type 1 diabetes




Brain damage



Medical condition Sample release date Recipient relationship Recipient age Unit volume Medical centre Country
Leukaemia Nov 2006 Allogeneic (Sibling) Restricted Restricted Stem Cells and Immunology
Department, Birmingham
Leukaemia Jan 2014 Allogeneic (Sibling) 4 Years 71ml Medizinische Hochschule, Hanover Germany
Thalassemia Nov 2005 Allogeneic (Sibling) 4 Years 144ml Mount Vernon Hospital Singapore
Thalassemia Feb 2007 Allogeneic (Sibling) 7 Years 76ml Kinderlink der Tu Munchen Germany
Thalassemia Oct 2013 Allogeneic (Sibling) 5 Years 58ml Catherine Lewis Centre, Hammersmith UK
Thalassemia Nov 2015 Allogeneic (Sibling) 12 Years 87ml Children’s Hospital of Pittsburgh of UPMC USA
Cerebral Palsy Aug 2009 Autologous (Self) 3 Years 51ml Duke University, North Carolina USA
Cerebral Palsy Jan 2010 Autologous (Self) 3 Years 81ml Duke University, North Carolina USA
Cerebral Palsy May 2014 Autologous (Self) 1 year 68ml Duke University, North Carolina USA
Cerebral Palsy Mar 2016 Allogeneic (Sibling) 6 Years 101ml Duke University, North Carolina USA
Cerebral Palsy Jun 2017 Autologous (Self) 7 Years 82ml Duke University, North Carolina USA
Cerebral Palsy Jun 2017 Autologous (Self) 3.5 Years 132ml Duke University, North Carolina USA
Cerebral Palsy Jun 2019 Allogeneic (Sibling) 3 Years 104ml Duke University, North Carolina USA
Autism Mar 2018 Autologous (Self) 5.4 Years 73ml Duke University, North Carolina USA
Acute Lymphocytic Leukaemia Apr 2011 Allogeneic (Sibling) 8 Years 130ml Royal Marsden Hospital UK
Lymphoblastic Leukaemia (^1) Apr 2017 N/A (Identical twin girls) Restricted 125ml Bambin Gesu Childrens’ Hospital, Rome Italy
HSV Encephalitis & NMDA Receptor Antibody Virus Jun 2014 Autologous (Self) 2 Years 57ml Duke University, North Carolina USA
Sickle Cell Disease May 2015 Allogeneic (Sibling) 2 .5 Years 57ml BLK Hospital, New Delhi India
Hypoxic Ischemic Encephalopathy (HIE) Aug 2014 Autologous (Self) 3 Months 39ml Duke University, North Carolina USA
Hypoxic Ischemic Encephalopathy (HIE) Feb 2015 Autologous (Self) 6 Months 53ml Duke University, North Carolina USA
Severe Combined Immune Deficiency Mar 2015 Autologous (Self) 3 Months 74ml Duke University, North Carolina USA

Join Professor Mark Johnson as he enlightens us on the revolutionary possibilities of Cord Blood Banking.

Although the public at large is still unaware of stem cells, for patients suffering from leukaemia and other related blood conditions, undergoing a stem cell transplant could very well mean the difference between life and death.

Professor Johnson — a distinguished Consultant Obstetrician for Chelsea and Westminster Hospital NHS Foundation Trust, as well as an esteemed Consultant in General Medicine, Endocrinology and Diabetes — elucidates the advantages of cord blood stem cell banking. He declares that storing baby’s stem cells is a critical decision to make.